SoftOx Solutions AS (OSL:SOFTX)
Norway · Delayed Price · Currency is NOK 0.1112
+0.0034 (3.15%)
At close: Jun 24, 2026
SoftOx Solutions AS Company Description
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that anti-infective therapy for airway infections in Norway.
The company develops SIS-03, a lead clinical program that is in phase 2a to treatment of chronic airway infections.
It also developing pan antimicrobial pharmaceuticals targeting bacteria, viruses, yeast, spores, and fungi.
SoftOx Solutions AS was founded in 2012 and is based in Lysaker, Norway.
SoftOx Solutions AS
| Country | Norway |
| Founded | 2012 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Thomas Bjarnsholt |
Contact Details
Address: Fridtjof Nansens vei 16 Lysaker, 1364 Norway | |
| Phone | 47 91 87 61 65 |
| Website | soft-ox.com |
Stock Details
| Ticker Symbol | SOFTX |
| Exchange | Oslo Børs |
| Fiscal Year | January - December |
| Reporting Currency | NOK |
| ISIN Number | NO0010811961 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Thomas Bjarnsholt | Chief Executive Officer, Chief Medical Officer and Chief Scientific Officer |
| Ulrik Spork | Executive Chairman of the Board |
| Ingrid Juven | Chief Operating Officer and Chief Financial Officer |
| Charlotte Pinholt | Head of CMC |
| Elin Lisby Kastberg Jørgensen | International Senior Project Manager |